To Get Help Now
Click Here
Today's Date:

Lawsuit Says Fosamax Causes Atypical Fracture

AddThis Social Bookmark Button

The national law firm of Parker Waichman LLP has filed a lawsuit in Superior Court of New Jersey, Atlantic county Law Division on behalf of a South Carolina woman who suffered an atypical femur fracture of her right thigh allegedly because of the bone-loss drug Fosamax. The lawsuit names Merck Sharp & Dohme Corp., and Merck & Co., as defendants.

According to the lawsuit, the plaintiff began taking Fosamax in December 2005 and suffered a fracture in her right thigh in 2010. The plaintiff says that bisphosphonates like Fosamax were designed to treat the bone loss that occurs with osteoporosis and osteopenia, however, the lawsuit says the drug can actually increase the risk fracture, and causes bones to because more brittle. Further, the lawsuit says that the manufacturer knew or should have known about this risk, yet failed to warn consumers and their physicians, while continuing to market the drug as a treatment.

The lawsuit alleges severe physical and mental pain and suffering, emotional distress, permanent injuries, and economic loss due to medical expenses and living expenses due to the requirements of a new lifestyle. Among other things, the lawsuit seeks compensatory, punitive, and statutory damages. disclaimer: This article: Lawsuit Says Fosamax Causes Atypical Fracture was posted on Monday, July 30th, 2012 at 6:05 pm at and is filed under Defective Drug Lawsuits, Uncategorized.

« »

Comments are closed.